---
title: "VC isn't VC anymore — understanding the rise of Cancer Capital"
slug: vc-isnt-vc-anymore-understanding-the-rise-of-cancer-capital
url: https://listedarticles.com/articles/vc-isnt-vc-anymore-understanding-the-rise-of-cancer-capital
canonical_url: https://www.anildash.com/2026/09/02/cancer-capital/
content_type: essay
language: en
published_at: 2026-09-02T12:00:00.000Z
updated_at: 2026-09-16T16:12:39.726Z
author: "Anil Dash"
author_url: https://www.anildash.com/
authored_by: agent
publisher: "Anil Dash"
publisher_url: https://www.anildash.com
topics: ["Venture Capital", "Tech Industry", "Power", "Economics", "Startups", "Politics"]
license: all-rights-reserved
word_count: 320
reading_minutes: 1
citation: "Anil Dash, Anil Dash. \"VC isn't VC anymore — understanding the rise of Cancer Capital.\" 2 Sept 2026. https://www.anildash.com/2026/09/02/cancer-capital/ (all-rights-reserved)"
# The full text follows. The web page shows an extract and sends readers
# to the source above; quote the citation and link the canonical URL.
---

# VC isn't VC anymore — understanding the rise of Cancer Capital

> Anil Dash, writing from experience as a startup CEO and board member, argues that a handful of mega-funds have transformed venture capital from a risk-bearing minority of the capital markets into an unaccountable oligarchic force he calls "Cancer Capital." The piece explains how 2% management fees on $50 billion funds insulate these firms from any market discipline while giving them the power to shape policy, politics, and the direction of the tech industry.

> **Indexed summary.** This entry is an agent-written synopsis of an article first published at [anildash.com](https://www.anildash.com/2026/09/02/cancer-capital/). Read the original for the full text.

Dash opens by distinguishing the VC most people imagine — a fund that bets on founders and shares the risk — from the reality of a few enormous firms that have merged private equity with venture, manage tens of billions in assets, and collect annual management fees large enough to sustain them regardless of portfolio performance.

The core mechanism he identifies is that once a firm manages enough capital, the 2% annual fee becomes a self-sustaining revenue stream. A $50 billion fund generates a billion dollars a year whether any company it funds succeeds or fails. At that scale, the firm is no longer a venture capital fund in any regulatory or economic sense, freeing it from the accountability structures applied to either.

## Key points

- Traditional VC was designed to be a small, high-risk slice of diversified portfolios; its expansion into a dominant default funding path for startups has distorted incentives.
- The largest firms now buy founder shares directly, hold unlimited public stock, and sell portfolio positions between their own funds — moves unavailable to regulated VCs.
- The shift in power has flipped the founder-investor relationship: large funds now effectively recruit founders to execute pre-existing theses rather than backing independent ideas.
- Pension funds and retail retirement accounts are increasingly the limited partners, meaning ordinary workers carry risk for strategies they never chose.
- Andreessen Horowitz spent $115 million in the 2026 midterm cycle, more than any individual donor in the country.

## Why it matters

Dash's framing offers a structural explanation for several tech-industry trends that otherwise appear unrelated: platform enshittification, data centre lobbying, and the concentration of AI infrastructure in a small number of companies. Understanding the incentive architecture helps explain why these outcomes keep appearing across different sectors and companies.

---

*Source: [VC isn't VC anymore — understanding the rise of Cancer Capital](https://www.anildash.com/2026/09/02/cancer-capital/)*